[SCHEDULE 13G/A] Immunome Inc. Amended Passive Investment Disclosure
T. Rowe Price reports 17.4% stake in Immunome
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 19,676,883 shares of Immunome, Inc. common stock, representing 17.4% of the class.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 19,676,883 shares of Immunome, Inc. common stock, representing 17.4% of the class. It has sole voting power over 19,656,814 shares and sole dispositive power over 19,676,883 shares, with no shared voting or dispositive power.
The shares are held for advisory clients, who retain the right to receive dividends and sale proceeds, and may revoke delegated authority. The T. Rowe Price Small-Cap Stock Fund has an interest in 7,179,563 shares, representing 6.5% of Immunome’s common stock. T. Rowe Price Investment Management expressly denies beneficial ownership beyond this reporting capacity.
Key Figures
Shares beneficially owned:19,676,883 sharesPercent of class:17.4%Sole voting power:19,656,814 shares+3 more
6 metrics
Shares beneficially owned19,676,883 sharesImmunome Inc common stock reported as beneficially owned by T. Rowe Price Investment Management, Inc.
Percent of class17.4%Portion of Immunome Inc common stock class attributed to T. Rowe Price Investment Management, Inc.
Sole voting power19,656,814 sharesShares of Immunome Inc over which T. Rowe Price Investment Management, Inc. has sole power to vote
Sole dispositive power19,676,883 sharesShares of Immunome Inc over which T. Rowe Price Investment Management, Inc. has sole power to dispose
Small-Cap Stock Fund holdings7,179,563 sharesImmunome Inc shares held by T. Rowe Price Small-Cap Stock Fund advised by T. Rowe Price Investment Management, Inc.
Small-Cap Stock Fund percent of class6.5%Portion of Immunome Inc common stock class held by T. Rowe Price Small-Cap Stock Fund
Key Terms
beneficially owned, sole voting power, sole dispositive power, Investment Company Act of 1940, +1 more
5 terms
beneficially ownedfinancial
"Amount beneficially owned: 19676883"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting powerfinancial
"Sole power to vote or to direct the vote: 19656814"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive powerfinancial
"Sole power to dispose or to direct the disposition of: 19676883"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment Company Act of 1940regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
discretionary authorityfinancial
"Any and all discretionary authority which has been delegated"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Immunome Inc (IMNM) does T. Rowe Price Investment Management report owning?
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 17.4% of Immunome Inc’s common stock, representing 19,676,883 shares over which it has sole dispositive power and substantial sole voting power on behalf of its advisory clients.
How many Immunome Inc (IMNM) shares does T. Rowe Price Investment Management control voting for?
T. Rowe Price Investment Management, Inc. has sole voting power over 19,656,814 shares of Immunome Inc common stock and no shared voting power, indicating it can vote those shares under its discretionary authority for clients.
What is the Immunome Inc (IMNM) stake of the T. Rowe Price Small-Cap Stock Fund?
The T. Rowe Price Small-Cap Stock Fund has an interest in 7,179,563 Immunome Inc shares, representing 6.5% of the common stock class. T. Rowe Price Investment Management serves as investment adviser to this fund and manages these holdings.
Who ultimately receives dividends and sale proceeds from T. Rowe Price’s Immunome Inc (IMNM) holdings?
Dividends and sale proceeds from the Immunome Inc shares are received by clients or their custodians, not by T. Rowe Price Investment Management. The ultimate power to direct receipt rests with individual and institutional clients it advises.
Does T. Rowe Price Investment Management claim full beneficial ownership of its Immunome Inc (IMNM) shares?
No. T. Rowe Price Investment Management expressly denies beneficial ownership of the Immunome Inc securities beyond its role as investment adviser. It states that clients, not the adviser, ultimately benefit from dividends and sale proceeds.
Can T. Rowe Price Investment Management’s authority over Immunome Inc (IMNM) shares be revoked?
Yes. Any discretionary authority delegated to T. Rowe Price Investment Management over Immunome Inc shares may be revoked in whole or in part at any time by its clients, who retain ultimate economic interest in the securities.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
IMMUNOME INC
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
45257U108
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
45257U108
1
Names of Reporting Persons
T. Rowe Price Investment Management, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MARYLAND
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
19,656,814.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
19,676,883.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
19,676,883.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
17.4 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
IMMUNOME INC
(b)
Address of issuer's principal executive offices:
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Item 2.
(a)
Name of person filing:
T. Rowe Price Investment Management, Inc.
(b)
Address or principal business office or, if none, residence:
1307 Point Street, Baltimore, MD 21231
(c)
Citizenship:
Maryland
(d)
Title of class of securities:
COMMON STOCK
(e)
CUSIP No.:
45257U108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
19676883
(b)
Percent of class:
17.4 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
19656814
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
19676883
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. (2) [T. ROWE PRICE SMALL-CAP STOCK FUND ]: T. ROWE PRICE SMALL-CAP STOCK FUND, of which T. Rowe Price Investment Management, Inc. is the investment adviser, holds the securities reported herein in their investment portfolio managed by T. Rowe Price Investment Management, Inc. and such funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that they hold. T. ROWE PRICE SMALL-CAP STOCK FUND has an interest in 7,179,563 of the class reported herein representing 6.5% of the class.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
